Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma.
Tavanti E, Sero V, Vella S, Fanelli M, Michelacci F, Landuzzi L, Magagnoli G, Versteeg R, Picci P, Hattinger CM, Serra M. Tavanti E, et al. Br J Cancer. 2013 Nov 12;109(10):2607-18. doi: 10.1038/bjc.2013.643. Epub 2013 Oct 15. Br J Cancer. 2013. PMID: 24129234 Free PMC article.
Advances in emerging drugs for osteosarcoma.
Hattinger CM, Fanelli M, Tavanti E, Vella S, Ferrari S, Picci P, Serra M. Hattinger CM, et al. Among authors: tavanti e. Expert Opin Emerg Drugs. 2015 Sep;20(3):495-514. doi: 10.1517/14728214.2015.1051965. Epub 2015 Jun 1. Expert Opin Emerg Drugs. 2015. PMID: 26021401 Review.
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
Hattinger CM, Biason P, Iacoboni E, Gagno S, Fanelli M, Tavanti E, Vella S, Ferrari S, Roli A, Roncato R, Giodini L, Scotlandi K, Picci P, Toffoli G, Serra M. Hattinger CM, et al. Among authors: tavanti e. Oncotarget. 2016 Sep 20;7(38):61970-61987. doi: 10.18632/oncotarget.11486. Oncotarget. 2016. PMID: 27566557 Free PMC article.
Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?
Hattinger CM, Fanelli M, Tavanti E, Vella S, Riganti C, Picci P, Serra M. Hattinger CM, et al. Among authors: tavanti e. Future Oncol. 2017 Apr;13(8):673-677. doi: 10.2217/fon-2016-0519. Epub 2017 Feb 10. Future Oncol. 2017. PMID: 28183198 Free article. No abstract available.
21 results